SEB Asset Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
SEB Asset Management's COGT Position: Q3 2026 in Review
SEB Asset Management held its Cogent Biosciences (COGT) position steady in Q3 2026 at 228,093 shares worth $7.3M. The position accounts for 0.03% of the portfolio, ranked #390.
SEB Asset Management first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.83M in Q2 2026. 314 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- SEB Asset Management held 228,093 shares of Cogent Biosciences worth $7.3M as of Q3 2026.
- SEB Asset Management left its Cogent Biosciences share count unchanged in Q3 2026.
- Cogent Biosciences made up 0.03% of SEB Asset Management's portfolio in Q3 2026, its #390 holding.
- SEB Asset Management first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
- SEB Asset Management's Cogent Biosciences position peaked at $8.83M in Q2 2026.
- 314 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.